Edge-to-Edge Percutaneous Repair of Severe Mitral Regurgitation
Key result
MitraClip therapy is a safe percutaneous procedure for severe mitral regurgitation, with survival outcomes in high-surgical-risk patients superior to historical controls.
Why the study?
Does percutaneous edge-to-edge repair (MitraClip) improve outcomes in patients with severe mitral regurgitation at high surgical risk?
Population
Patients with severe mitral regurgitation, primarily those at high risk for surgery
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports MitraClip in high-surgical-risk patients; leaves open durability and randomized confirmation.
Structured PICO
Does percutaneous edge-to-edge repair (MitraClip) improve outcomes in patients with severe mitral regurgitation at high surgical risk?
P
Population
Patients with severe mitral regurgitation, primarily those at high risk for surgery
I
Intervention
Percutaneous edge-to-edge plication of the mitral leaflets (MitraClip)
MitraClip is a safe percutaneous option for severe mitral regurgitation, particularly in high-surgical-risk patients, though long-term durability remains to be fully established.
Limitations
- Questions remain concerning long-term efficacy and durability
- Continued investigation is required to better define the patient populations that will benefit most
- Continued investigation is required to further better define the patient populations that will benefit most
Cite This Study
Alegría‐Barrero et al. (2012) conducted a review in Severe Mitral Regurgitation. MitraClip was evaluated. MitraClip therapy is a safe percutaneous procedure for severe mitral regurgitation, with survival outcomes in high-surgical-risk patients superior to historical controls.